11β-Hydroxysteroid Dehydrogenase-1 Is a Novel Regulator of Skin Homeostasis and a Candidate Target for Promoting Tissue Repair

11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus

(2010) G. Hollis et al.   DIABETES OBESITY & METABOLISM

Glucocorticoid reamplification within cells intensifies NF-κB and MAPK signaling and reinforces inflammation in activated preadipocytes

(2009) Takako Ishii-Yonemoto et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Mechanisms Generating Diversity in Glucocorticoid Receptor Signaling

(2009) Javier R. Revollo et al.   Annals of the New York Academy of Sciences

Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis

(2009) Marianne Demerjian et al.   EXPERIMENTAL DERMATOLOGY

Increased subcutaneous adipose tissue impairs dermal function in diet-induced obese mice

(2009) Tomonobu Ezure et al.   EXPERIMENTAL DERMATOLOGY

Tumor necrosis factor-α processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma

(2009) Mika Terao et al.   EXPERIMENTAL DERMATOLOGY

Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease

(2009) Nicholas Michael Morton   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Effects of extracellular calcium on the growth-differentiation switch in immortalized keratinocyte HaCaT cells compared with normal human keratinocytes

(2008) Ludovic Micallef et al.   EXPERIMENTAL DERMATOLOGY

A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis

(2008) I J Bujalska et al.   JOURNAL OF ENDOCRINOLOGY

Development of 11β -HSD1 Inhibitors for the Treatment of Type 2 Diabetes

(2008) Clarence Hale et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model

(2007) Nadja Nicole Zöller et al.   TOXICOLOGY IN VITRO